BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15911628)

  • 21. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis.
    Li D; Marchenko ND; Moll UM
    Cell Death Differ; 2011 Dec; 18(12):1904-13. PubMed ID: 21637290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-chaperone CHIP associates with mutant Cu/Zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomes.
    Choi JS; Cho S; Park SG; Park BC; Lee DH
    Biochem Biophys Res Commun; 2004 Aug; 321(3):574-83. PubMed ID: 15358145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CHIP: a quality-control E3 ligase collaborating with molecular chaperones.
    Murata S; Chiba T; Tanaka K
    Int J Biochem Cell Biol; 2003 May; 35(5):572-8. PubMed ID: 12672450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gambogic acid-induced degradation of mutant p53 is mediated by proteasome and related to CHIP.
    Wang J; Zhao Q; Qi Q; Gu HY; Rong JJ; Mu R; Zou MJ; Tao L; You QD; Guo QL
    J Cell Biochem; 2011 Feb; 112(2):509-19. PubMed ID: 21268072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein-Protein Interactions Modulate the Docking-Dependent E3-Ubiquitin Ligase Activity of Carboxy-Terminus of Hsc70-Interacting Protein (CHIP).
    Narayan V; Landré V; Ning J; Hernychova L; Muller P; Verma C; Walkinshaw MD; Blackburn EA; Ball KL
    Mol Cell Proteomics; 2015 Nov; 14(11):2973-87. PubMed ID: 26330542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proposal for a role of the Hsp90/Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage.
    Pratt WB; Morishima Y; Peng HM; Osawa Y
    Exp Biol Med (Maywood); 2010 Mar; 235(3):278-89. PubMed ID: 20404045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ubiquitylation of neuronal nitric-oxide synthase by CHIP, a chaperone-dependent E3 ligase.
    Peng HM; Morishima Y; Jenkins GJ; Dunbar AY; Lau M; Patterson C; Pratt WB; Osawa Y
    J Biol Chem; 2004 Dec; 279(51):52970-7. PubMed ID: 15466472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and assay of the chaperone-dependent ubiquitin ligase of the carboxyl terminus of Hsc70-interacting protein.
    Murata S; Minami M; Minami Y
    Methods Enzymol; 2005; 398():271-9. PubMed ID: 16275335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDM2 binding induces a conformational change in p53 that is opposed by heat-shock protein 90 and precedes p53 proteasomal degradation.
    Sasaki M; Nie L; Maki CG
    J Biol Chem; 2007 May; 282(19):14626-34. PubMed ID: 17363365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chaperone-assisted degradation: multiple paths to destruction.
    Kettern N; Dreiseidler M; Tawo R; Höhfeld J
    Biol Chem; 2010 May; 391(5):481-9. PubMed ID: 20302520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and stimulates the maturation of the cystic fibrosis transmembrane conductance regulator.
    Alberti S; Böhse K; Arndt V; Schmitz A; Höhfeld J
    Mol Biol Cell; 2004 Sep; 15(9):4003-10. PubMed ID: 15215316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of proto-oncogenic dbl by chaperone-controlled, ubiquitin-mediated degradation.
    Kamynina E; Kauppinen K; Duan F; Muakkassa N; Manor D
    Mol Cell Biol; 2007 Mar; 27(5):1809-22. PubMed ID: 17178836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AQP2 Abundance is Regulated by the E3-Ligase CHIP Via HSP70.
    Centrone M; Ranieri M; Di Mise A; Berlingerio SP; Russo A; Deen PMT; Staub O; Valenti G; Tamma G
    Cell Physiol Biochem; 2017; 44(2):515-531. PubMed ID: 29145196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bag1 directly routes immature BCR-ABL for proteasomal degradation.
    Tsukahara F; Maru Y
    Blood; 2010 Nov; 116(18):3582-92. PubMed ID: 20675402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promotion of CHIP-mediated p53 degradation protects the heart from ischemic injury.
    Naito AT; Okada S; Minamino T; Iwanaga K; Liu ML; Sumida T; Nomura S; Sahara N; Mizoroki T; Takashima A; Akazawa H; Nagai T; Shiojima I; Komuro I
    Circ Res; 2010 Jun; 106(11):1692-702. PubMed ID: 20413784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 Ubiquitination and proteasomal degradation.
    Love IM; Shi D; Grossman SR
    Methods Mol Biol; 2013; 962():63-73. PubMed ID: 23150437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hsp90 Chaperones Bluetongue Virus Proteins and Prevents Proteasomal Degradation.
    Mohl BP; Roy P
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MDM2 chaperones the p53 tumor suppressor.
    Wawrzynow B; Zylicz A; Wallace M; Hupp T; Zylicz M
    J Biol Chem; 2007 Nov; 282(45):32603-12. PubMed ID: 17848574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ubiquitin ligase CHIP/STUB1 targets mutant keratins for degradation.
    Löffek S; Wöll S; Höhfeld J; Leube RE; Has C; Bruckner-Tuderman L; Magin TM
    Hum Mutat; 2010 Apr; 31(4):466-76. PubMed ID: 20151404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHIP: a co-chaperone for degradation by the proteasome.
    Edkins AL
    Subcell Biochem; 2015; 78():219-42. PubMed ID: 25487024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.